How do you handle and document the disposal of non-conforming materials or products?

Auditee: Handling and documenting the disposal of non-conforming materials or products is a critical aspect of maintaining product quality, preventing their unintended use, and ensuring compliance with FDA regulations. Here’s how we handle and document the disposal process:

Identification and Segregation: Non-conforming materials or products are identified through various quality control checks, inspections, or testing procedures. Once identified, they are segregated from conforming materials to prevent mix-up or accidental use.

Non-Conformance Report (NCR): A non-conformance report is generated, detailing the nature of the non-conformance, the affected batch or lot number, the reason for non-conformance, and the corrective and preventive actions (CAPA) required.

Also Read: Modified-Release Capsules: GMP Controls for Pellets, Multiparticulates and Coatings

Decision Making: The decision is made whether the non-conforming materials or products can be reworked, if applicable, or if they need to be disposed of.

Disposal Plan: A disposal plan is developed, outlining the method and procedures for the safe disposal of the non-conforming materials or products. This plan considers environmental regulations and safety protocols.

Disposal Execution: The non-conforming materials or products are disposed of according to the approved disposal plan. This may involve methods such as destruction, incineration, or recycling, depending on the nature of the materials.

Documentation: Detailed documentation of the disposal process is maintained:

Disposal Record: A record is created, detailing the

date, time, method, and personnel involved in the disposal process.

Environmental Compliance: If the disposal involves hazardous materials, documentation ensures compliance with environmental regulations and reporting requirements.

Verification and Audit: The disposal process is subject to verification and potential audit to ensure that it was executed as planned and in compliance with FDA regulations and our internal procedures.

Effectiveness Assessment: The effectiveness of the disposal process is evaluated to ensure that the non-conforming materials or products have been effectively removed from circulation and pose no risk to product quality or patient safety.

Continuous Improvement: The disposal process is subject to continuous improvement efforts. Any issues or inefficiencies encountered during disposal are used as opportunities for process enhancement.

Through this systematic approach, we ensure that non-conforming materials or products are disposed of in a controlled and documented manner, in compliance with regulatory requirements and our commitment to product quality and safety.